Therefore, in addition to ROCK inhibition, targeting proteins such as LIMK and myosin that work downstream of ROCK in the regulation of the actomyosin cytoskeleton may have anti-tumor therapeutic benefits by counteracting the effects of cellular tension on the microenvironment.